References
- Committee of Clinical Practice Guideline of the Korean Society of Lipid and Atherosclerosis (KSoLA). Korean Guidelines for the Management of Dyslipidemia 4th ed. The Korean Society of Lipid and Atherosclerosis. 2018.(Korean)
- Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, et al., European Atherosclerosis Society Consensus Panel. Triglyceriderich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345-61. DOI: https://doi.org/10.1093/eurheartj/ehr112
- Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood-Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(Suppl 2):S1-S45. DOI: https://doi.org/10.1161/01.cir.0000437738.63853.7a
- Hong YK, Kim SS, Shin MK, Kim JJ. Review of Korean Medical Treatment in Hyperlipidemia-Focusing on Treatment of Korean Herbal Medicine. Korean J. Oriental Physiology & Pathology. 2010;24(1):9-14. (Korean)
- Kim EY, Kim JW. A Clinical study on the Sasang Constitution and Obesity. J of Sasang Constitutional Medicine. 2004;16(1);100-111. (Korean)
- Guo M, Liu Y, Gao ZY, Shi DZ. Chinese herbal medicine on dyslipidemia: progress and perspective. Evidence-Based Complementary and Alternative Medicine. 2014;163036. DOI: http://dx.doi.org/10.1155/2014/163036
- Liu C, Huang Y. Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action. Front Pharmacol. 2016;7;469. DOI: https://doi.org/10.3389/fphar.2016.00469
- Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report. J of Clin Lipidol. 2015;9(2):129-69. DOI: http://dx.doi.org/10.1016/j.jacl.2015.02.003
- Reiner Z. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14(7):401-11. DOI: http://dx.doi.org/10.1038/nrcardio.2017.31
- Stephen R. Daniels MD, PhD, Sarah C. Couch PhD, RD. Pediatric Endocrinology (FOURTH EDITION). 2014. p.1015-1034.
- Jeon SH, Yu JS, Lee EJ. Clinical Practice Guideline for Taeeumin Disease of Sasang Constitutional Medicine: Liver Heat-based Interior Heat (Gansuyeol-liyeol) disease. J Sasang Constitut Med 2015;27(1):57-70. (Korean) DOI: http://dx.doi.org/10.7730/JSCM.2015.27.1.057
- No HT, Kim YK. Effect of Gamichungshimtang (GCST) on Circulatory System and Brain Damage. J of Oriental. Chr. Dis. 1998;4(1);176-202. (Korean)
- Yoon YS, Keum SO, Lee SW, Kim IH, Lee HI, Song YS. Effects of Cheongshimyeonja-tang on Body Weight and Serum Lipid Levels in High Fat Diet Induced Obese Mice. Herbal Formula Science(HFS). 2014;22(1):123-139. (Korean) DOI: http://dx.doi.org/10.14374/HFS.2014.22.1.123
- Yoo SR, Jeong SJ, Shin HK. Effects of Yeoldahansotang, a Sasang Constitutional Herbal Prescription for Taeeumin, on the Adipogenesis in 3T3-L1 Cells. J Sasang Constitut Med 2012;24(4):75-83. (Korean) DOI: http://dx.doi.org/10.7730/JSCM.2012.24.4.75
- Song YK, CHA YY, Ko SG. Analysis of the Obesity-Related Research for Each Constituent Herb of Euiiin-tang. J Korean Med Obes Res. 2014;14(2):72-79. (Korean) DOI: http://dx.doi.org/10.15429/jkomor.2014.14.2.72